Fundraising FoxTorus Biosystems
Cambridge, US · Founded 2019 · Delaware corporation · 2 known investors
Find your way into Torus Biosystems
Founders & leadership
SM
Shawn MarcellExecutive
BL
Ben LindenExecutiveBen Linden is a CPA and financial professional with experience at publicly held and private corporations, including roles managing mergers and acquisitions, SEC reporting, and financial planning for companies with revenues up to $200 million. He has led execution of over $700 million in financing and M&A transactions, including venture capital and bank debt arrangements, and oversaw integration of a $200 million company with 1,800+ employees.
DY
David Yu ZhangNamed on SEC filing
PY
Peng YinNamed on SEC filing
Board
AW
Adam WiechhausBoard director
Investors · 2
Illumina VenturesreportedFoster City
How we know: a partner's Signal profile · Not right? Tell us
Northpond VenturesreportedBethesda · $100K – $5M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$28.9M disclosed across 3 rounds · 2020–2021
▶$25.2MraisedMay 2021 · 6 investors · BiotechnologyRule 506(b)
▶$25.2MraisedMay 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David Yu ZhangDirector
- Peng YinDirector
- Shawn MarcellExecutive Officer, Director
- Ben LindenExecutive Officer
- Adam WiechhausDirector
- Offering amount
- $25.2M
- Amount sold
- $25.2M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.2MraisedMar 2021 · 4 investors · BiotechnologyRule 506(b)
▶$2.2MraisedMar 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn MarcellExecutive Officer, Director
- Ben LindenExecutive Officer
- David Yu ZhangDirector
- Peng YinDirector
- Offering amount
- $3M
- Amount sold
- $2.2M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedFeb 2020 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chenyang Victor ShiDirector
- David Yu ZhangDirector
- Philip GardellaExecutive Officer
- Peng YinExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Torus Biosystems's investors?
- Torus Biosystems's investors include Illumina Ventures, Northpond Ventures.
- How much funding has Torus Biosystems raised?
- Torus Biosystems has disclosed $28.9M raised across 3 rounds.
- Where is Torus Biosystems headquartered?
- Torus Biosystems is headquartered in Cambridge, US.